FAAH and Alzheimer disease: Here we showed that FAAH expression is significantly higher in the monocytes of AD patients, and that its pharmacological inhibition in monocytes and monocyte-derived macrophages modulates the reduction in pro-inflammatory cytokines and subverts the immunophenotype of M1-like macrophages towards a more pro-resolving one.